We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-20.46%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.64B
AUM Growth
+$440M
Cap. Flow
+$940M
Cap. Flow %
57.18%
Top 10 Hldgs %
44.47%
Holding
4,515
New
888
Increased
1,264
Reduced
882
Closed
1,360

Sector Composition

Rank Sector Weight
1 Financials 4.56%
2 Industrials 3.56%
3 Consumer Discretionary 3.21%
4 Technology 3.1%
5 Healthcare 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZNH
4201
DELISTED
China Southern Airlines Company Limited
ZNH
-300
Closed -$10K
CEA
4202
DELISTED
China Eastern Airlines
CEA
-300
Closed -$8K
BNFT
4203
DELISTED
Benefitfocus, Inc.
BNFT
-1,545
Closed -$34K
BRMK.WS
4204
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$0 ﹤0.01%
894
SPNE
4205
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-939
Closed -$11K
OYST
4206
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
-431
Closed -$11K
CHRA
4207
DELISTED
Charah Solutions, Inc Common Stock
CHRA
-135
Closed -$3K
AATC
4208
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
-95
Closed
RBCN
4209
DELISTED
Rubicon Technology, Inc.
RBCN
-388
Closed -$3K
CLVS
4210
DELISTED
Clovis Oncology, Inc.
CLVS
-222
Closed -$2K
PHCF
4211
DELISTED
Puhui Wealth Investment Management Co., Ltd.
PHCF
$0 ﹤0.01%
+15
New +$196
LOTZ
4212
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
-100
Closed -$1K
PBFX
4213
DELISTED
PBF LOGISTICS LP
PBFX
-2,436
Closed -$49K
ZEN
4214
DELISTED
ZENDESK INC
ZEN
-318
Closed -$24K
AERI
4215
DELISTED
Aerie Pharmaceuticals
AERI
-2,693
Closed -$65K
CYBE
4216
DELISTED
Cyberoptics Corp
CYBE
-1,317
Closed -$24K
USWS
4217
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
-9
Closed
SRLP
4218
DELISTED
SPRAGUE RESOURCES LP
SRLP
-2,719
Closed -$46K
CCXI
4219
DELISTED
ChemoCentryx, Inc.
CCXI
-4,993
Closed -$197K
RJI
4220
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
$0 ﹤0.01%
100
RMO
4221
DELISTED
Romeo Power, Inc.
RMO
$0 ﹤0.01%
6
-794
-99% -$7.92K
CVET
4222
DELISTED
Covetrus, Inc. Common Stock
CVET
-2,163
Closed -$29K
GBT
4223
DELISTED
Global Blood Therapeutics, Inc.
GBT
-4,888
Closed -$389K
ABTX
4224
DELISTED
Allegiance Bancshares
ABTX
-128
Closed -$5K
GCP
4225
DELISTED
GCP Applied Technologies Inc.
GCP
-183
Closed -$4K

Similar funds

Tower Research Capital (TRC)'s Q1 2020 Portfolio in Review

As of Q1 2020, Tower Research Capital (TRC) held 4,515 positions worth $1.64B, up 37% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tower Research Capital (TRC) deployed $940M of net new capital in Q1 2020, opening 888 new positions and adding to 1,264 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 2.5% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $87.2M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2020 buy was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $101M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $87.2M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2020, selling an estimated $19.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 44% of its $1.64B portfolio in Q1 2020.
  • Tower Research Capital (TRC) opened 888 new positions and closed 1,360 in Q1 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.64B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.